Abstract
Aldehyde dehydrogenase (E.C. 1.2.1.3) is a polymorphic enzyme that is relatively substrate-nonspecific. Several isoenzymes are found in human tissues. Based on primary structure or subcellular distribution and kinetic, physical and immunochemical properties, they have been placed into one of three classes, viz., class 1, e.g., ALDH-1, class 2, e.g., ALDH-2 and class 3, e.g., ALDH-3 (Anonymous, 1989; Lindahl and Hempel, 1990; Goedde and Agarwal, 1990; Lindahl, 1992). These enzymes catalyze the biotransformation (bioactivation and/or bioinactivation) of a broad spectrum of endogenous (biogenic) and exogenous (xenobiotic) aldehydes that are physiologically and/or pharmacologically important (Sladek et al., 1989, 1995; Lindahl, 1992; Sladek, 1993, 1994). For example, ALDH-1 catalyzes the oxidation of retinaldehyde to retinoic acid, the latter being a potent modulator of cell growth and differentiation; ALDH-1 and, especially, ALDH-2 catalyze the oxidation of ethanol-derived acetaldehyde to acetate, a detoxifying reaction; ALDH-3 catalyzes the oxidation of 4-hydroxynonenal and other aldehydic products of lipid peroxidation to their corresponding acids, also a detoxifying reaction; and ALDH-1 and ALDH-3 catalyze the oxidation of aldophosphamide to carboxyphosphamide, yet another detoxifying reaction, since, alternatively, aldophosphamide, a metabolite of anticancer prodrugs collectively known as oxazaphosphorines, e.g., cyclophosphamide, gives rise to phosphoramide mustard, the metabolite that effects the cytotoxic action of these prodrugs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anonymous: Nomenclature of mammalian aldehyde dehydrogenases. Prog. Clin. Biol. Res. 290 (1989) xix–xxi.
Blatter, E.E., Abriola, D.P. and Pietruszko, R.: Aldehyde dehydrogenase. Covalent intermediate in aldehyde dehydrogenation and ester hydrolysis. Biochem. J. 282 (1992) 353–360.
Bostian, K.A. and Betts, G.F.: Kinetics and reaction mechanism of potassium-activated aldehyde dehydrogenase from Saccharomyces cerevisiae. Biochem. J. 173 (1978) 787–798.
Bradford, M.M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248–254.
Brien, J.F. and Loomis, C.W.: Aldehyde dehydrogenase inhibitors as alcohol-sensitizing drugs: a pharmacological perspective. Trends Pharmacol. Sci. (1985) 477–480.
Bunting, K.D. and Townsend, A.J.: Protection by transfected rat or human class 3 aldehyde dehydrogenases against the cytotoxic effects of oxazaphosphorine alkylating agents in hamster V79 cell lines. J. Biol. Chem. 271 (1996) 11891–11896.
Chueh, S.-H., Chang, G.-G., Chang, T.-C. and Pan, F.: Involvement of arginine residue in the phosphate binding site of human placental alkaline phosphatase. Int. J. Biochem. 13 (1981) 1143–1149.
Dickinson, F.M. and Haywood, G.W.: The role of the metal ion in the mechanism of the K+-activated aldehyde dehydrogenase of Saccharomyces cerevisiae. Biochem. J. 247 (1987) 377–384.
Dockham, P.A., Lee, M.-O. and Sladek, N.E.: Identification of human liver aldehyde dehydrogenases that catalyze the oxidation of aldophosphamide and retinaldehyde. Biochem. Pharmacol. 43 (1992) 2453–2469.
Farrés, J., Wang, T.T.Y., Cunningham, S.J. and Weiner, H.: Investigation of the active site cysteine residue of rat liver mitochondrial aldehyde dehydrogenase by site-directed mutagenesis. Biochemistry 34 (1995) 2592–2598.
Feldman, R.I. and Weiner, H.: Horse liver aldehyde dehydrogenase. II. Kinetic and mechanistic implications of the dehydrogenase and esterase activity. J. Biol. Chem. 247 (1972) 267–272.
Goedde, H.W. and Agarwal, D.P.: Pharmacogenetics of aldehyde dehydrogenase (ALDH). Pharmacol. Ther. 45 (1990) 345–371.
Kitson, T.M., Hill, J.P. and Midwinter, G.G.: Identification of a catalytically essential nucleophilic residue in sheep liver cytoplasmic aldehyde dehydrogenase. Biochem. J. 275 (1991) 207–210.
Klyosov, A.A., Rashkovetsky, L.G., Tahir, M.K. and Keung, W.-M.: Possible role of liver cytosolic and mitochondrial aldehyde dehydrogenases in acetaldehyde metabolism. Biochemistry 35 (1996) 4445–4456.
Lambeir, A.-M., Loiseau, A.M., Kuntz, D.A., Vellieux, F.M., Michels, P.A.M. and Opperdoes, F.R.: The cytosolic and glycosomal glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma brucei. Kinetic properties and comparison with homologous enzymes. Eur. J. Biochem. 198 (1991) 429–435.
Lee, M.J.C., Elberling, J.A. and Nagasawa, H.T.: N1-Hydroxylated derivatives of chlorpropamide and its analogs as inhibitors of aldehyde dehydrogenase in vivo. J. Med. Chem. 35 (1992a) 3641–3647.
Lee, M.J.C., Nagasawa, H.T., Elberling, J.A. and DeMaster, E.G.: Prodrugs of nitroxyl as inhibitors of aldehyde dehydrogenase. J. Med. Chem. 35 (1992b) 3648–3652.
Lindahl, R.: Aldehyde dehydrogenases and their role in carcinogenesis. Crit. Rev. Biochem. Mol. Biol. 27 (1992) 283–335.
Lindahl, R. and Hempel, J.: Aldehyde dehydrogenases: what can be learned from a baker’s dozen sequences. Adv. Exp. Med. Biol. 284 (1990) 1–8.
Little, R.G. II and Petersen, D.R.: Effect of tolbutamide and chlorpropamide on acetaldehyde metabolism in two inbred strains of mice. Toxicol. Appl. Pharmacol. 80 (1985) 206–214.
Logie, A.W., Galloway, D.B. and Petrie, J.C.: Drug interactions and long-term antidiabetic therapy. Br. J. Clin. Pharmacol. 3 (1976) 1027–1032.
Moreb, J., Schweder, M., Suresh, A. and Zucali, J.R.: Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxycyclophosphamide. Cancer Gene Ther. 3 (1996) 24–30.
Mukerjee, N. and Pietruszko, R.: Human mitochondrial aldehyde dehydrogenase substrate specificity: comparison of esterase with dehydrogenase reaction. Arch. Biochem. Biophys. 299 (1992) 23–29.
Mukerjee, N. and Pietruszko, R.: Inactivation of human aldehyde dehydrogenase by isosorbide dinitrate. J. Biol. Chem. 269 (1994) 21664–21669.
Nagasawa, H.T., DeMaster, E.G., Kwon, C.-H., Fraser, P.S. and Shirota, F.N.: Structure vs. activity in the sulfony-lurea-mediated disulfiram-ethanol reaction. Alcohol 2 (1985) 123–128.
Nagasawa, H.T., Elberling, J.A., Shirota, F.N. and DeMaster, E.G.: A nonhypoglycemic chlorpropamide analog that inhibits aldehyde dehydrogenase. Alcohol. Clin. Exp. Res. 12 (1988) 563–565.
Nagasawa, H.T., Elberling, J.A., DeMaster, E.G. and Shirota, F.N.: N1-Alkyl-substituted derivatives of chlorpropamide as inhibitors of aldehyde dehydrogenase. J. Med. Chem. 32 (1989) 1335–1340.
Nagasawa, H.T., Kawle, S.P., Elberling, J.A., DeMaster, E.G. and Fukuto, J.M.: Prodrugs of nitroxyl as potential aldehyde dehydrogenase inhibitors vis-à -vis vascular smooth muscle relaxants. J. Med. Chem. 38 (1995) 1865–1871.
Öhlin, H., Jerntorp, P., Bergström, B. and Almér, L-O.: Chlorpropamide-alcohol flushing, aldehyde dehydrogenase activity, and diabetic complications. Brit. Med. J. 285 (1982) 838–840.
Peachey, J.E.: A review of the clinical use of disulfiram and calcium carbimide in alcoholism treatment. J. Clin. Psychopharmacol. 1 (1981) 368–375.
Petersen, E.N.: The pharmacology and toxicology of disulfiram and its metabolites. Acta Psychiatr. Scand. 86 (1992) 7–13.
Rekha, G.K. and Sladek, N.E.: Inhibition of human class 3 aldehyde dehydrogenase, and sensitization of tumor cells that express significant amounts of this enzyme to oxazaphosphorines, by the naturally occuring compound gossypol. In Weiner, H., Lindahl, R., Crabb, D.W. and Flynn, T.G. (Eds.) Enzymology and Molecular Biology of Carbonyl Metabolism — 6, Plenum Press, New York, 1997.
Rekha, G.K., Sreerama, L. and Sladek, N.E.: Intrinsic cellular resistance to oxazaphosphorines exhibited by a human colon carcinoma cell line expressing relatively large amounts of a class-3 aldehyde dehydrogenase. Biochem. Pharmacol. 48 (1994) 1943–1952.
Saigal, D., Cunningham, S.J., Farrés, J. and Weiner, H.: Molecular cloning of the mitochondrial aldehyde dehydrogenase gene of Saccharomyces cerevisiae by genetic complementation. J. Bacteriol. 173 (1991) 3199–3208.
Sambrook, J., Fritsch, E.F. and Maniatis, T.: Preparation and transformation of competent E. coli. In Molecular Cloning: A Laboratory Manual, 2nd edition, Cold Spring Harbor Laboratory Press, 1989, pp. 1.74–1.84.
Sellers, E.M., Naranjo, C.A. and Peachey, J.E.: Drugs to decrease alcohol consumption. New Eng. J. Med. 305 (1981) 1255–1262.
Sidhu, R.S. and Blair, A.H.: Human liver aldehyde dehydrogenase. Esterase activity. J. Biol. Chem. 250 (1975) 7894–7898.
Sladek, N.E.: Oxazaphosphorine-specific acquired cellular resistance. In Teicher, B.A. (Ed.), Drug Resistance in Oncology, Marcel Dekker, N.Y., 1993, pp. 375–411.
Sladek, N.E.: Metabolism and pharmacokinetic behavior of cyclophosphamide and related oxazaphosphorines. In Powis, G. (Ed.), Anticancer Drugs: Reactive Metabolism and Drug Interactions, Pergamon Press, United Kingdom, 1994, pp. 79–156.
Sladek, N.E., Manthey, C.L., Maki, P.A., Zhang, Z. and Landkamer, G.L.: Xenobiotic oxidation catalyzed by aldehyde dehydrogenases. Drug Metab. Rev. 20 (1989) 697–720.
Sladek, N.E., Sreerama, L. and Rekha, G.K.: Constitutive and overexpressed human cytosolic class-3 aldehyde dehydrogenases in normal and neoplastic cells/secretions. Adv. Exp. Med. Biol. 372 (1995) 103–114.
Sreerama, L. and Sladek, N.E.: Identification and characterization of a novel class 3 aldehyde dehydrogenase overexpressed in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific acquired resistance. Biochem. Pharmacol. 45 (1993) 2487–2505.
Sreerama, L. and Sladek, N.E.: Identification of a methylcholanthrene-induced aldehyde dehydrogenase in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific acquired resistance. Cancer Res. 54 (1994) 2176–2185.
Sreerama, L. and Sladek, N.E.: Human breast adenocarcinoma MCF-7/0 cells electroporated with cytosolic class 3 aldehyde dehydrogenases obtained from tumor cells and normal tissue exhibit differential sensitivity to mafosfamide. Drug Metab. Dispos. 23 (1995) 1080–1084.
Sreerama, L. and Sladek, N.E.: Class 1 and class 3 aldehyde dehydrogenase levels in the human tumor cell lines currently used by the National Cancer Institute to screen for potentially useful antitumor agents. In Weiner, H., Lindahl, R., Crabb, D.W. and Flynn, T.G. (Eds.) Enzymology and Molecular Biology of Carbonyl Metabolism — 6, Plenum Press, New York, 1997.
Sreerama, L., Rekha, G.K. and Sladek, N.E.: Phenolic antioxidant-induced overexpression of class-3 aldehyde dehydrogenase and oxazaphosphorine-specific resistance. Biochem. Pharmacol. 49 (1995) 669–675.
Watanabe, A., Hobara, N. and Nagashima, H.: Activation and inhibition of yeast aldehyde dehydrogenase activity by pantethine and its metabolites. Ann. Nutr. Metab. 30 (1986) 54–57.
Wilkinson, G.N.: Statistical estimations in enzyme kinetics. Biochem. J. 80 (1961) 324–332.
Zheng, C.-F., Wang, T.T.Y. and Weiner, H.: Cloning and expression of the full-length cDNAs encoding human liver class 1 and class 2 aldehyde dehydrogenases. Alcohol. Clin. Exp. Res. 17 (1993) 828–831.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Devaraj, V.R., Sreerama, L., Lee, M.J.C., Nagasawa, H.T., Sladek, N.E. (1996). Yeast Aldehyde Dehydrogenase Sensitivity to Inhibition by Chlorpropamide Analogues as an Indicator of Human Aldehyde Dehydrogenase Sensitivity to These Agents. In: Weiner, H., Lindahl, R., Crabb, D.W., Flynn, T.G. (eds) Enzymology and Molecular Biology of Carbonyl Metabolism 6. Advances in Experimental Medicine and Biology, vol 414. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5871-2_18
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5871-2_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7692-7
Online ISBN: 978-1-4615-5871-2
eBook Packages: Springer Book Archive